Home › Funds › PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. › EBS

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. position in EBS

EMERGENT BIOSOLUTIONS INC · Health Care

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. reported holding 1,143,481 shares of EBS (EMERGENT BIOSOLUTIONS INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 0.68% of its reported portfolio and ranking #38 among its reported holdings. PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. has disclosed EBS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.14M sh
Reported value held$7.55M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s EBS position evolved

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in EBS in Q3 2023 at 299,187 shares (US$1.0M). The position peaked in Q4 2025 at 772,771 shares, worth US$9.6M. Across 11 filings, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,143,481 shares valued at US$7.5M — an increase of 370,710 shares quarter over quarter.. Notable position changes include a 185% increase in Q4 2023 (shares rose 5% over the following quarter), a 250% increase in Q4 2024 (shares fell 49% over the following quarter), a 199% increase in Q1 2025 (shares rose 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 299.19K $1.02M New
Q4 2023 853.35K $2.05M Add
Q3 2024 60.00K $501.00K New
Q4 2024 210.00K $2.01M Add
Q1 2025 627.67K $3.05M Add
Q2 2025 772.77K $4.93M Add
Q3 2025 772.77K $6.82M Hold
Q4 2025 772.77K $9.55M Hold
Q1 2026 772.77K $6.41M Hold
Q2 2026 772.77K $6.48M Hold
Q3 2026 1.14M $7.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EBS and 13F data

EBS (EMERGENT BIOSOLUTIONS INC) is a Health Care company. 23 other funds we track also report a position in EBS — the largest reported positions include OAK HILL ADVISORS LP (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EBS

All EBS fund holders →

FAQ

How long has PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. held EBS?

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. has disclosed EBS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s current position in EBS?

As of Q3 2026, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. holds 1.14M shares of EBS (EMERGENT BIOSOLUTIONS INC), valued at $7.55M, representing 0.68% of its reported portfolio and ranking #38.

Has PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. been buying or selling EBS?

In the latest 13F filing (Q3 2026), PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. increased its position in EBS. The position peaked in Q4 2025 at 772.77K shares.

Which other funds hold EBS?

Other major institutional holders of EBS include OAK HILL ADVISORS LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.